Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer

Clinical trial NCT03298087 · COMPLETED

Trial details

NCT number: NCT03298087
Sponsor: VA Office of Research and Development
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Newly Diagnosed Oligometastatic Prostate Cancer

Start date: 2018-07-01
Primary completion: 2024-03-31
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.